{"id":119539,"date":"2024-12-20T14:53:26","date_gmt":"2024-12-20T14:53:26","guid":{"rendered":"https:\/\/quixnet.net\/wpinstance\/novo-nordisk-shares-plunge-after-cagrisema-obesity-drug-trial-disappoints-reuters\/"},"modified":"2024-12-20T14:53:26","modified_gmt":"2024-12-20T14:53:26","slug":"novo-nordisk-shares-plunge-after-cagrisema-obesity-drug-trial-disappoints-reuters","status":"publish","type":"post","link":"https:\/\/quixnet.net\/wpinstance\/novo-nordisk-shares-plunge-after-cagrisema-obesity-drug-trial-disappoints-reuters\/","title":{"rendered":"Novo Nordisk shares plunge after CagriSema obesity drug trial disappoints &#8211; Reuters"},"content":{"rendered":"<ol>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMi4wFBVV95cUxNYTIxajliX25yb0dKTTgwa0JjLW1xQklCckZCUmNIaVM5bjBzdXdfTGItcmRhZ3BrUU9hN0k0NUhjUkRqNTdhaEJiSV9GZHBMMEZ5YkMza3pFYWMtellIOXBiOGtSTDNKbGhPanZWSE14MWFmZHpTZ0dhSkU1MDBneTFmX1dpa2VURGx0ZXpsQm8zeDdvb3FON29GX3YxREtkVzh3UmhwVGlmT1J0VDA0Mnl6eFkwWkFiR3l3OHlUaV9fSkF1TllvUU9KQVBmbHlwRzJHRDJ3X1RWWExhdW1qTHNCMA?oc=5\" target=\"_blank\">Novo Nordisk shares plunge after CagriSema obesity drug trial disappoints<\/a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters<\/font><\/li>\n<li><a href=\"https:\/\/news.google.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?oc=5\" target=\"_blank\">Novo Nordisk shares plunge 20% after disappointing trial results; Lilly jumps in premarket<\/a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CNBC<\/font><\/li>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMijwFBVV95cUxQa3g5S1VScHJhVlM5RDN3VGVrenBGRnB4QkRPTDN4YXlkTlpzenYxNjRhWlYzT1JhOEt0b0UxSURsbnE5YXRYSFBLMmZ5WWN1QVNMVlNfVUF4VV94MWoyRWJkV0lucDZNVnJaMTB4Zlk1VzZBcUotdl9MSUJyYTJkQVkwQy1YcGxDaFBxRVdGdw?oc=5\" target=\"_blank\">Novo Nordisk stock price takes a tumble after the Wegovy maker&#8217;s next-generation weight-loss drug underwhelms<\/a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fast Company<\/font><\/li>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMirgFBVV95cUxQNUFia253X2lfeExQclpQSjkwcmZVWEZnTk13WTh6Wkd4THFFbi02NGlnYlUyaFVpdlpxWUljZFpFZ3BBWFhSV0E2YlNHQWRNNS1JY05OTlk5U1VyWlBERHZUUzJJYy1NUkhiRHRoMVdYS0pCYmMzSzVfX0h3bmh5SnJucVIwRm9EQzNTdmhVMHpCOTdKZ2NGWlByTzUzTmx4NEVlUUNnWmNYX3ZMX1E?oc=5\" target=\"_blank\">Novo Nordisk Falls Most on Record After New Weight Drug Disappoints<\/a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Bloomberg<\/font><\/li>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMif0FVX3lxTE5aUDdOeWVtbVdxUy1fZkdMaVQ2Znd2cHNFVjRGVzdIeFBTRW9Bamk1NFlCQVVoODlDTmRWUER2VlZaVGx6Sk9kb191cHczSWYtQTdHV0JtN2VORDIwWmNZd3BySG5jMnh3XzNiUW5sbTNnSUYtblNYVC13WGtvaXM?oc=5\" target=\"_blank\">Novo Nordisk A\/S (NVO) Fell as its Weight Loss Drug Faced Supply Constraints<\/a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance<\/font><\/li>\n<\/ol>\n<p><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMi4wFBVV95cUxNYTIxajliX25yb0dKTTgwa0JjLW1xQklCckZCUmNIaVM5bjBzdXdfTGItcmRhZ3BrUU9hN0k0NUhjUkRqNTdhaEJiSV9GZHBMMEZ5YkMza3pFYWMtellIOXBiOGtSTDNKbGhPanZWSE14MWFmZHpTZ0dhSkU1MDBneTFmX1dpa2VURGx0ZXpsQm8zeDdvb3FON29GX3YxREtkVzh3UmhwVGlmT1J0VDA0Mnl6eFkwWkFiR3l3OHlUaV9fSkF1TllvUU9KQVBmbHlwRzJHRDJ3X1RWWExhdW1qTHNCMA?oc=5\">source<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Novo Nordisk shares plunge after CagriSema obesity drug trial disappoints&nbsp;&nbsp;Reuters Novo Nordisk shares plunge 20% after disappointing trial results; Lilly jumps in premarket&nbsp;&nbsp;CNBC Novo Nordisk stock price takes a tumble after the Wegovy maker&#8217;s next-generation weight-loss drug underwhelms&nbsp;&nbsp;Fast Company Novo Nordisk Falls Most on Record After New Weight Drug Disappoints&nbsp;&nbsp;Bloomberg Novo Nordisk A\/S (NVO) Fell [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":119540,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"categories":[4],"tags":[],"class_list":{"0":"post-119539","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-breaking-news-video","8":"entry"},"_links":{"self":[{"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/posts\/119539","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/comments?post=119539"}],"version-history":[{"count":0,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/posts\/119539\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/media\/119540"}],"wp:attachment":[{"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/media?parent=119539"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/categories?post=119539"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/tags?post=119539"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}